Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated September 22, 2020, titled "SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics".
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated September 22, 2020, titled "SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics".